The final goal is to maximize the preservation of visual function with approaches including panretinal photocoagulation (PRP), anti-vascular endothelial growth factor (VEGF) therapy, anti-glaucoma therapy including drug therapy and surgical interventions, management of the systemic disease and intensive follow-up at the same time (12, 51, 58, 59). Here, VEGFA is linked to glaucoma.